Literature DB >> 19222607

Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells.

Hiroyuki Tanaka1, Tsuyoshi Fukushima, Kenji Yorita, Makiko Kawaguchi, Hiroaki Kataoka.   

Abstract

Hepatocyte growth factor activator inhibitor-1 (HAI-1) is a Kunitz-type transmembrane serine proteinase inhibitor that inhibits trypsin-like serine proteinases, such as hepatocyte growth factor activator, matriptase, hepsin and prostasin. HAI-1 is expressed in polarized epithelial cells, in which HAI-1 is mainly located on the basolateral membrane. In the present study, we analyzed the expression and distribution of HAI-1 in respiratory epithelium. We found that HAI-1 is expressed by the bronchial respiratory epithelium with basal or basolateral localization and also by the alveolar epithelium. Bronchial expression of HAI-1 was also confirmed using cultured human bronchial epithelial cells. The epithelial expression of HAI-1 was augmented in response to tissue injury such as cancer invasion and inflammation. Surprisingly, in the injured pulmonary tissue, HAI-1 showed distinct apical translocation in ciliated epithelial cells of the bronchiole. We suggest that, in addition to its basolateral surface localization, HAI-1 can transiently localize to the apical surface of respiratory ciliated epithelial cells under conditions of severe inflammation, possibly interacting with a specific cellular proteinase on the apical surface.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222607     DOI: 10.1111/j.1749-0774.2008.00062.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  29 in total

1.  Prostasin is a glycosylphosphatidylinositol-anchored active serine protease.

Authors:  L M Chen; M L Skinner; S W Kauffman; J Chao; L Chao; C D Thaler; K X Chai
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

2.  Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.

Authors:  Yutaka Akiyama; Miyuki Nagai; Wataru Komaki; Kousuke Marutsuka; Yujiro Asada; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

3.  Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters.

Authors:  H Itoh; H Kataoka; J Y Meng; R Hamasuna; N Kitamura; M Koono
Journal:  Biochim Biophys Acta       Date:  2001-05-28

4.  Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Authors:  Daniel Kirchhofer; Mark Peek; Michael T Lipari; Karen Billeci; Bin Fan; Paul Moran
Journal:  FEBS Lett       Date:  2005-03-28       Impact factor: 4.124

5.  Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.

Authors:  R Szabo; A Molinolo; K List; T H Bugge
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

6.  Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.

Authors:  Sarah Netzel-Arnett; Brooke M Currie; Roman Szabo; Chen-Yong Lin; Li-Mei Chen; Karl X Chai; Toni M Antalis; Thomas H Bugge; Karin List
Journal:  J Biol Chem       Date:  2006-09-15       Impact factor: 5.157

7.  Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin.

Authors:  Bin Fan; Thomas D Wu; Wei Li; Daniel Kirchhofer
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

8.  Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis.

Authors:  Luis E Gómez-Quiroz; Valentina M Factor; Pal Kaposi-Novak; Cedric Coulouarn; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  J Biol Chem       Date:  2008-03-18       Impact factor: 5.157

9.  Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.

Authors:  Koki Nagaike; Makiko Kawaguchi; Naoki Takeda; Tsuyoshi Fukushima; Akira Sawaguchi; Kazuyo Kohama; Mitsuru Setoyama; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 10.  Type II transmembrane serine proteases in development and disease.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Int J Biochem Cell Biol       Date:  2007-12-04       Impact factor: 5.085

View more
  3 in total

Review 1.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

2.  Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3.

Authors:  Michel Fausther; Julie Pelletier; Carla M Ribeiro; Jean Sévigny; Maryse Picher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-26       Impact factor: 5.464

3.  Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Authors:  Kazuyo Kohama; Makiko Kawaguchi; Tsuyoshi Fukushima; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2012-12-18       Impact factor: 4.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.